Early surgical intervention for asymptomatic cervical spinal cord compression only has modest quality of life improvements while having variable cost-effectiveness, according to a study in the June 2026 issue of The Spine Journal.
Seven things to know:
1. The study evaluated the cost-effectiveness of early anterior cervical discectomy and fusion compared to observation in patients with asymptomatic cervical spinal cord compression.
2. Researchers used a state-transition Markov model from the U.S. healthcare payer perspective, simulating a lifetime horizon for an economic evaluation.
3. A hypothetical cohort of 10,000 patients, aged to reflect a typical Medicare population was modeled.
4. Seven health states were modeled: asymptomatic, mild, moderate, severe myelopathy, postoperative without complications, postoperative with complications, and death.
5. In the base case, observation had 15.01 QALYs at a discounted cost of $8,066 per patient. Early ACDF saw 15.26 QALYs at $28,106, an incremental cost of $20,040 and a QALY gain of 0.241.
6. Early intervention showed that early surgery became cost-effective only when annual progression risks exceeded ∼3.5% from asymptomatic→mild or ∼11% from mild→moderate myelopathy.
7. The study concluded: “Early surgery for ACSCC is not cost-effective under current progression estimates but may be justified in high-risk patients with rapid progression. These findings support a risk-stratified approach, emphasizing early intervention only for patients with predictive biomarkers or imaging features of deterioration.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
